Yesterday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw two of its insiders unload stock. Neil Stahl, the company’s Senior Vice President of Research and Development, disposed of 11,646 shares of Common Stock yesterday. The sale was executed directly and in three smaller batches: the largest, 9,829 shares, was sold for a weighted average price of $340.04 per share, while another 1,617 shares were sold for $339.33 per share. The remaining 200 shares were unloaded for $341.27 for each share. Following one of many completed dispositions, the insider now owns a total of 13,527 shares.
The second insider to unload stock yesterday was Roy Vagelos, Chairman of the Board at the $34.1 billion market cap biopharmaceutical firm. The insider disposed of 9,372 shares of Common Stock, receiving $340.02 per share for 9,072 shares and $341.02 for each of the remaining 300 shares.
Regarding hedge funds, Q1 showed several new shareholding positions, such as Andreas Halvorsen’s Viking Global, which acquired over 1.05 million company shares with an estimated value of $315.8 million, making it one of the largest shareholders at Regeneron.